Γ

SynBioBeta Speaker

Zara Butte

Human Longevity

Physician

Zara Butte, M.D. is a board-certified internal medicine physician and clinical strategist. She practices at Human Longevity, Inc., where she focuses on early disease detection, risk stratification, and advanced diagnostics. Her clinical approach incorporates precision medicine techniques and integrative approaches to health and longevity, especially for women. Dr. Butte also advises companies at various stages on clinical product development, operations, and strategy.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Sessions Featuring

Zara

This Year

Femtech

12:00 PM

-

12:45 PM

Human Health

Early Detection. Precision Intervention. Real-World Deployment.

From circulating tumor DNA to AI-enabled diagnostics, liquid biopsies are collapsing the distance between biology and clinical action. This chamber convenes the scientists and clinicians leading that collapse — researchers who are not theorizing about the future of oncology, but building it: earlier signals, sharper targeting, smarter monitoring, and interventions that meet patients where the disease actually lives.

Femtech

12:00 PM

-

12:45 PM

Human Health

Early Detection. Precision Intervention. Real-World Deployment.

From circulating tumor DNA to AI-enabled diagnostics, liquid biopsies are collapsing the distance between biology and clinical action. This chamber convenes the scientists and clinicians leading that collapse — researchers who are not theorizing about the future of oncology, but building it: earlier signals, sharper targeting, smarter monitoring, and interventions that meet patients where the disease actually lives.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include